startups

From the collapse of biotech firm Theranos to the recent bankruptcy of crypto exchange FTX, the prevailing need for proper governance in privately-owned companies is gaining more attention. These high-profile start-ups, which can be sizeable in terms of valuation, do not fall into the purview of regulators or are not publicly listed. Therefore, such regulatory arbitrage or the lack of public scrutiny may result in the firm being susceptible to governance failures if sufficient checks and balances are not in place.